Crossing biological membranes: Engineering the cell-environment interface to improve process efficiency

穿过生物膜:设计细胞-环境界面以提高过程效率

基本信息

  • 批准号:
    BB/L013703/1
  • 负责人:
  • 金额:
    $ 119.34万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2014
  • 资助国家:
    英国
  • 起止时间:
    2014 至 无数据
  • 项目状态:
    已结题

项目摘要

Moving molecules across biological membranes represents a barrier to improving the efficiency of many existing Industrial Biotechnology and Bio-Energy (IBBE) processes that utilize cell factories. The reason for this is the perceived difficulties of working with membrane proteins and the often cell-toxic effects of the uncontrolled expression of transporters as well as the toxicity associated with the accumulation of products. Furthermore, with the advent of synthetic biology, identifying appropriate transport systems for integration into the regulatory and energetic networks of a chassis organism will be crucial in expanding the economic and social impacts of IBBE by facilitating the development of novel processes. The motivation for this network is that a deeper understanding of how substances are transported into, within, and out of cell factories will lead to the development of enabling technologies that are crucial for the future development of almost all cell-based IBBE applications, including the bottom-up design of systems (synthetic biology). This network proposal is timely because many proof-of-concept bio-production systems have been established, but few provide commercially acceptable product concentrations, often because the desired product proves to be toxic to the producing cell-factories. The goal is to develop innovative solutions and technologies to overcome yield restrictions, due to inefficient transport systems, in existing IBBE processes and to embed fully-integrated efficient transport systems into the design of the novel IBBE activities of the future. One the many strengths of this network bid is the cross-cutting nature of its focus such that its outputs will impact on almost all cell-factory-based IBBE processes. Thus our network is uniquely positioned to synergistically interact with other Networks in Industrial Biotechnology and Bioenergy (NIBB), as well as more widely. To achieve our goals we propose to assemble a managed five-year cross-disciplinary network of academics, industrial partners and other stakeholders to facilitate and deliver events to foster a multi-disciplinary knowledge-base focused on systems that transport substrates and products across membranes. This activity will lead to the creation of enabling technologies and biological systems with improved IBBE capacity.We envisage four major levels of activity within the network:1. We will create a cohesive community by bringing experts from different relevant disciplines together to share knowledge, identify key questions/bottlenecks, forge collaborations and create innovative solutions.2. We will support multi-disciplinary, collaborative research focussed on 'real' IBBE problems through a robust, competitive Proof-of-Concept funding program that includes biological, engineering and social scientific elements. 3. We will promote knowledge gathering and exchange through visits to participating laboratories and conference attendance.4. We will engage with the broader national and international research community, including other NIBBs to exchange knowledge and best practice, learned scientific societies and wider society via an interactive website and outreach events. We envisage five major outputs from the network:1. Enhanced interactions between academic institutions, IB companies and NIBBs to build partnerships that will channel wider research activity towards removing bottlenecks in existing IBBE processes and opening new IBBE opportunities.2. Identifying the major challenges presented by need for effective and efficient transport systems for the future development of synthetic biology based IBBE processes.3. Supporting the development of enabling technologies through Proof-of-Concept funding.4. Forming multi-disciplinary teams to compete in relevant funding calls promoting translational research activities.5. Creative early career scientists with networks of connections across academia and industry.
移动分子穿过生物膜代表了提高利用细胞工厂的许多现有工业生物技术和生物能源(IBBE)过程的效率的障碍。其原因是膜蛋白工作的困难和转运蛋白不受控制的表达的通常细胞毒性作用以及与产物积累相关的毒性。此外,随着合成生物学的出现,确定适当的运输系统整合到底盘有机体的监管和充满活力的网络将是至关重要的,在扩大IBBE的经济和社会影响,促进新工艺的发展。这个网络的动机是,更深入地了解物质如何被运输到细胞工厂,内部和外部,将导致开发对几乎所有基于细胞的IBBE应用的未来发展至关重要的使能技术,包括自下而上的系统设计(合成生物学)。这个网络的建议是及时的,因为许多概念验证的生物生产系统已经建立,但很少提供商业上可接受的产品浓度,往往是因为所需的产品被证明是有毒的生产细胞工厂。其目标是开发创新的解决方案和技术,以克服现有IBBE工艺中由于运输系统效率低下而造成的产量限制,并将完全集成的高效运输系统嵌入到未来新型IBBE活动的设计中。该网络竞标的众多优势之一是其重点的跨领域性质,其产出将影响几乎所有基于细胞工厂的IBBE流程。因此,我们的网络具有独特的优势,可以与工业生物技术和生物能源(NIBB)以及更广泛的其他网络协同互动。为了实现我们的目标,我们建议组建一个由学者,工业合作伙伴和其他利益相关者组成的五年期跨学科网络,以促进和提供活动,以培养一个多学科的知识库,重点是跨膜运输基质和产品的系统。这项活动将导致创建使能技术和生物系统,提高IBBE能力。我们设想网络内的四个主要活动级别:1.我们将通过将不同相关学科的专家聚集在一起来创建一个有凝聚力的社区,以分享知识,确定关键问题/瓶颈,建立合作关系并创建创新解决方案。我们将通过一个强大的,有竞争力的概念验证资助计划,包括生物,工程和社会科学元素,支持多学科,合作研究集中在“真实的”IBBE问题。3.我们将通过访问参与实验室和参加会议来促进知识收集和交流。我们将与更广泛的国家和国际研究界,包括其他NIBB,通过互动网站和外联活动交流知识和最佳实践,学术科学协会和更广泛的社会。我们设想网络的五个主要产出:1。加强学术机构、IB公司和NIBB之间的互动,建立伙伴关系,将更广泛的研究活动引向消除现有IBBE过程中的瓶颈,开辟新的IBBE机会。确定未来发展基于合成生物学的IBBE工艺所需的有效和高效运输系统所面临的主要挑战。4.通过概念验证资助,支持开发赋能技术。形成多学科团队竞争相关基金要求促进转化研究活动。具有创造力的早期职业科学家,拥有学术界和工业界的联系网络。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CBMNet: the 'Crossing Biological Membranes' network in industrial biotechnology and bioenergy.
CBMNet:工业生物技术和生物能源领域的“跨越生物膜”网络。
Structural basis of malodour precursor transport in the human axilla.
  • DOI:
    10.7554/elife.34995
  • 发表时间:
    2018-07-03
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Minhas GS;Bawdon D;Herman R;Rudden M;Stone AP;James AG;Thomas GH;Newstead S
  • 通讯作者:
    Newstead S
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J Green其他文献

Questioning the usefulness of 24-hour recall of exclusive breastfeeding
质疑 24 小时回忆纯母乳喂养的有用性
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K Nanishi;J Green;A Shibanuma;H Hongo
  • 通讯作者:
    H Hongo
Effects of magnesium supplementation on erythrocyte cation transport in diuretic-treated hypertensives
  • DOI:
    10.1016/s0271-5317(89)80151-4
  • 发表时间:
    1989-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    MB Zemel;J Green;PC Zemel;F Douglas;R Geiser;JR Sowers
  • 通讯作者:
    JR Sowers
EE735 A New Post-Diagnostic Psycho-Education and Acceptance and Commitment Therapy Program for Caregivers of Children Recently Diagnosed With Autism Spectrum Disorder (REACH-ASD): A Trial-Based Cost-Effectiveness Analysis
EE735 一项针对近期被诊断患有自闭症谱系障碍儿童的照顾者的新的诊断后心理教育与接受与承诺疗法方案(REACH-ASD):一项基于试验的成本效益分析
  • DOI:
    10.1016/j.jval.2024.10.1015
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    G Shields;A Rowlandson;L Davies;K Leadbitter;J Green
  • 通讯作者:
    J Green
Substrate specificity of soluble methane monooxygenase: Mechanistic implications
  • DOI:
    10.1016/s0021-9258(19)84627-6
  • 发表时间:
    1989-10-25
  • 期刊:
  • 影响因子:
  • 作者:
    J Green;H Dalton
  • 通讯作者:
    H Dalton
EE232 Collecting Economic Data From Global Autism Spectrum Disorder (ASD) Research: A Comparison From the UK and India
EE232 从全球自闭症谱系障碍(ASD)研究中收集经济数据:来自英国和印度的比较
  • DOI:
    10.1016/j.jval.2024.10.514
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    R Roy;G Shields;P Verma;SS Dash;D Jangra;J Green;K Leadbitter;G Divan
  • 通讯作者:
    G Divan

J Green的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J Green', 18)}}的其他基金

Enhanced Biofuel Production via Integrated Microbubble Technology
通过集成微泡技术提高生物燃料生产
  • 批准号:
    EP/N011511/1
  • 财政年份:
    2016
  • 资助金额:
    $ 119.34万
  • 项目类别:
    Research Grant
A new pathway for iron-sulfur cluster repair
铁硫簇修复的新途径
  • 批准号:
    BB/L008114/1
  • 财政年份:
    2014
  • 资助金额:
    $ 119.34万
  • 项目类别:
    Research Grant
Integrating cAMP- and nitric oxide- signalling in Mycobacterium tuberculosis: novel regulatory networks that challenge established paradigms
在结核分枝杆菌中整合 cAMP 和一氧化氮信号传导:挑战既定范例的新型调控网络
  • 批准号:
    BB/K000071/1
  • 财政年份:
    2012
  • 资助金额:
    $ 119.34万
  • 项目类别:
    Research Grant
The mechanism of oxygen sensing by the global transcriptional regulator FNR
全局转录调节因子 FNR 的氧传感机制
  • 批准号:
    BB/G018960/1
  • 财政年份:
    2010
  • 资助金额:
    $ 119.34万
  • 项目类别:
    Research Grant
Characterization of an anaerobic Escherichia coli K-12 cyclic-di-GMP phosphodiesterase
厌氧大肠杆菌 K-12 环二 GMP 磷酸二酯酶的表征
  • 批准号:
    BB/G006024/1
  • 财政年份:
    2009
  • 资助金额:
    $ 119.34万
  • 项目类别:
    Research Grant
The Escherichia coli YfiD protein: an oxygen and acidity responsive regulator of carbon flux
大肠杆菌 YfiD 蛋白:碳通量的氧和酸度响应调节剂
  • 批准号:
    BB/E019943/1
  • 财政年份:
    2007
  • 资助金额:
    $ 119.34万
  • 项目类别:
    Research Grant

相似国自然基金

生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
  • 批准号:
    82371332
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
过表达CX45联合HCN4基因转染对起搏细胞自律性的影响
  • 批准号:
    81170174
  • 批准年份:
    2011
  • 资助金额:
    50.0 万元
  • 项目类别:
    面上项目
美洲大蠊药材养殖及加工过程中化学成分动态变化与生物活性的相关性研究
  • 批准号:
    81060329
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
慢病毒转染嵌合体HCN1+4拼接基因构建生物起搏细胞
  • 批准号:
    81070139
  • 批准年份:
    2010
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目
岭南瑶区几种瑶族抗肝炎植物药的化学成分及生物活性研究
  • 批准号:
    20772047
  • 批准年份:
    2007
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目
TB方法在有机和生物大分子体系计算研究中的应用
  • 批准号:
    20773047
  • 批准年份:
    2007
  • 资助金额:
    26.0 万元
  • 项目类别:
    面上项目
天然生物材料的多尺度力学与仿生研究
  • 批准号:
    10732050
  • 批准年份:
    2007
  • 资助金额:
    200.0 万元
  • 项目类别:
    重点项目

相似海外基金

Decoding dynamic interplay between signaling and membranes in chemotaxis bymolecular actuators
通过分子致动器解码趋化中信号传导和膜之间的动态相互作用
  • 批准号:
    10846921
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Shifting paradigms to emerging toxins in freshwater cyanobacterial blooms
淡水蓝藻水华中新出现的毒素的范式转变
  • 批准号:
    10912318
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Mechanisms of Neural Synchrony in the Medial Entorhinal Cortex
内侧内嗅皮层神经同步机制
  • 批准号:
    10751561
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers
纳米级低聚物诱导的纳米膜调节
  • 批准号:
    10790511
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Calcium control of Neurotransmitter Release
钙控制神经递质释放
  • 批准号:
    10718229
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Structural study of biological membranes by Cryo-EM
利用冷冻电镜研究生物膜的结构
  • 批准号:
    23H02439
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Unraveling mechanisms by which cervicovaginal microbiota can promote or prevent cervical remodeling and preterm birth
揭示宫颈阴道微生物群促进或预防宫颈重塑和早产的机制
  • 批准号:
    10800388
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Intracellular functions and mechanisms of alphavirus ion channel 6K
甲病毒离子通道6K的细胞内功能和机制
  • 批准号:
    10727819
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Mechanisms of Neurodegeneration in CMT4B3: a Complex Pediatric Neurodevelopmental Disorder
CMT4B3 神经退行性变的机制:一种复杂的小儿神经发育障碍
  • 批准号:
    10750509
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
Decoding dynamic interplay between signaling and membranes in chemotaxis by molecular actuators
通过分子致动器解码趋化中信号传导和膜之间的动态相互作用
  • 批准号:
    10623376
  • 财政年份:
    2023
  • 资助金额:
    $ 119.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了